A large-scale study has identified five new genetic loci (points on the genome) associated with the health of the human lung and pulmonary function. Publishing in the latest edition of the journal Nature Genetics, the partly EU-funded researchers explain that their findings shed new light on the molecular basis of…
Marketing experts say drugmakers played DTC safe in 2009. Big Pharma reduced expensive network television advertising and took a hard look at which brands should get DTC support, Medical Marketing & Media reports. And they reconsidered just how to measure the effectiveness of their consumer-advertising campaigns. Drugmakers
Indian drugmaker Cipla is in talks with multinational and leading generic drug companies, including GlaxoSmithKline and Israel’s Teva, to supply generic drugs, its chairman said Monday. Report
Original Source of Cipla could supply meds to GSK, Teva
In a move that’s sure to be dissected–and possibly imitated–two Harvard Medical School teaching hospitals have
FiercePharma took a little break over the holidays. The newsletter has been on hiatus since Christmas Eve, but we checked in daily with some news on the website. And because we know many of you took a holiday vacation as well, here’s a roundup of what you may have…
We didn’t have to wait long for Nestle and Novartis to do their deal. Novartis will buy the rest of Nestle’s stake in Alcon, the eye care company, for $28.1 billion, and it’s offering to buy out minority shareholders–all 23 percent worth–as well. Here’s the math: Novartis paid $10.4…
Novartis announced that the World Health Organization (WHO) has granted prequalification for all three of its influenza A(H1N1) 2009 monovalent vaccines for supply to United Nations (UN) agencies: the cell culture-based and MF59® adjuvanted vaccine Celtura®, the egg-based and MF59 adjuvanted vaccine Focetria® as well as the egg-based A(H1N1) vaccine…
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has not yet completed its review of the Biologics License Application (BLA) for Prevnar 13™, (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s candidate 13-valent pneumococcal conjugate vaccine.
Original Source of Pfizer Provides U.S. Regulatory Update On Prevnar…
Soon we’ll have more data on prescription drug safety during pregnancy. To get around the obvious problem with safety trials in pregnant women–who’d volunteer?– the FDA is funding a retrospective analysis of data gathered on about 1 million births between 2001 and 2007, the agency says. Researchers from Vanderbilt…